Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Take the naloxone challenge

Matthew Zuckerman, MD
Meds
March 26, 2019
Share
Tweet
Share

Last week I took the naloxone challenge. I walked up to a pharmacy window, waited in line, and requested naloxone from the pharmacist. She showed a supportive but knowing look, and I became acutely aware of the four people in line behind me. After giving her my name and date of birth, she was able to pull my insurance info from prior visits, and I left with a dose of life-saving naloxone in my pocket. All it cost me was some embarrassment, some privacy, and $30.

Naloxone is an antidote to heroin and opioid overdose. While it normally requires a prescription from a doctor, 49 states have created standing orders that allow pharmacists to distribute it without a prescription, but that isn’t good enough. Well-intentioned medical directors, pharmacists, and legislators have spent countless hours setting up separate standing orders in each jurisdiction, trying to work around a regulatory framework that makes it easier to buy Rogaine than naloxone. It’s a mistake to think that this is the solution. The solution is making naloxone over the counter (OTC) nationally.

Patients at risk for opioid overdose often face a significant amount of stigma from family, strangers, and medical providers. They keep their drug use a secret and may be reluctant to go to a neighborhood pharmacy and ask for naloxone under a standing order. They can buy acetaminophen, condoms, even needles, and alcohol swabs online or in an anonymous self-checkout line, but they have to walk into the local Walgreens and give their name to get naloxone. Many emergency departments, clinics, and treatment centers distribute naloxone, but a minority of people at risk of overdose end up there. The stereotype of the addict in an urban ED or a treatment center ignores the reality that opioid addiction is as common as some cancers. Education about the dangers of opioid overdose has increased awareness of naloxone, but increasing safe, anonymous access will keep patients safer.

Pharmacies have standard operating procedures meant to keep patients safe and ensure payment. This means linking the medication to the patient chart and insurance and all the issues that come with that. Some have reported difficulty getting life insurance after filling a prescription for naloxone. Children or spouses may be concerned that insurance records may unmask their opioid use. Privacy concerns are very real, especially as patients have discovered that their medication history may be sold by pharmacies to drug companies for future marketing. The lack of an anonymous way to get OTC naloxone discourages people with opioid use disorder and those that care about them from doing the right thing and having naloxone on hand.

The barrier to OTC status is largely due to regulatory hurdles and delayed actions by pharmaceutical companies, many of which already make money selling both opioids and the naloxone that reverses them. Because naloxone is already available as a prescription medication, what is required is a prescription to OTC switch. The law requires that a drug being considered for such a switch has labeling that allows someone to self-diagnose and treat overdose, not require a health practitioner, that there is low potential for misuse/abuse, and a high safety margin that benefits outweigh risks. Anyone familiar with opioid overdose knows that this is true about naloxone. It has virtually no effects in people without opioid dependence, and it’s most severe effects occur when it is used to save a life following an overdose — a clear benefit in excess of risk. Recently such a label has been crafted by the FDA, but the FDA does not perform drug trials. Next steps require drug companies who currently make naloxone to apply for the switch. Previous approaches by such companies have led to the talking naloxone auto-injector that seems to complicate rather than solve the problem.

I’d encourage you to take the #NaloxoneChallenge, give your information to the pharmacist, feel their eyes on you, and walk out with naloxone in your pocket. You’ve done nothing wrong, you probably don’t have an issue with opioids, but ask yourself how you feel. Wonder if your spouse is going to ask about this charge at Walgreens. And then send a letter to your congressperson asking what they’re doing to get OTC naloxone.

Matthew Zuckerman is an emergency medicine physician.

Image credit: Shutterstock.com

Prev

The patient-clinician relationship matters. To all of us.

March 26, 2019 Kevin 0
…
Next

What doctors should learn from taxi drivers

March 27, 2019 Kevin 2
…

Tagged as: Emergency Medicine, Pain Management

Post navigation

< Previous Post
The patient-clinician relationship matters. To all of us.
Next Post >
What doctors should learn from taxi drivers

ADVERTISEMENT

Related Posts

  • I challenge you to discuss death

    Emily S. Hagen, MD
  • Legal challenge from Disability Rights Texas may have repercussions in schools across the country

    Eva Kittay, PhD
  • Denying payment for emergency care: a physician defends insurers

    Michael Kirsch, MD
  • A prayer from an emergency physician

    Edwin Leap, MD
  • The climate crisis as viewed by an emergency physician

    Elizabeth M. Barreras-Rivest, MD
  • Emergency care coverage denial policies put lives at risk

    Paul Kivela, MD, MBA

More in Meds

  • Why kratom addiction is the next public health crisis

    Muhamad Aly Rifai, MD
  • FDA delays could end vital treatment for rare disease patients

    GJ van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • Most Popular

  • Past Week

    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • Why physician strikes are a form of hospice

      Patrick Hudson, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Why heart and brain must work together for love

      Felicia Cummings, MD | Physician
    • Who are you outside of the white coat?

      Annia Raja, PhD | Conditions
    • How hospitals can prepare for CMS’s new patient safety rule

      Kim Adelman, PhD | Conditions
    • Physician practice ownership: risks, rewards, and reality

      Paul Morton, CFP | Finance
    • How peer support can save physician lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why AI in health care needs the same scrutiny as chemotherapy

      Rafael Rolon Rivera, MD | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • Love, birds, and fries: a story of innocence and connection

      Dr. Damane Zehra | Physician
    • How a doctor defied a hurricane to save a life

      Dharam Persaud-Sharma, MD, PhD | Physician
    • Why physician strikes are a form of hospice

      Patrick Hudson, MD | Physician
    • What street medicine taught me about healing

      Alina Kang | Education
    • The silent cost of choosing personalization over privacy in health care

      Dr. Giriraj Tosh Purohit | Tech
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • Confessions of a lipidologist in recovery: the infection we’ve ignored for 40 years

      Larry Kaskel, MD | Conditions
    • Why taxing remittances harms families and global health care

      Dalia Saha, MD | Finance
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • Why heart and brain must work together for love

      Felicia Cummings, MD | Physician
    • Who are you outside of the white coat?

      Annia Raja, PhD | Conditions
    • How hospitals can prepare for CMS’s new patient safety rule

      Kim Adelman, PhD | Conditions
    • Physician practice ownership: risks, rewards, and reality

      Paul Morton, CFP | Finance
    • How peer support can save physician lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why AI in health care needs the same scrutiny as chemotherapy

      Rafael Rolon Rivera, MD | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...